BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33299378)

  • 1. P-MAPA, a Fungi-Derived Immunomodulatory Compound, Induces a Proinflammatory Response in a Human Whole Blood Model.
    Gonçalves MT; Squaiella-Baptistão CC; Pidde G; Lopes PH; da Silva Nunes I; Tambourgi DV
    Mediators Inflamm; 2020; 2020():8831389. PubMed ID: 33299378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-MAPA activates TLR2 and TLR4 signaling while its combination with IL-12 stimulates CD4+ and CD8+ effector T cells in ovarian cancer.
    Silveira HS; Lupi LA; Romagnoli GG; Kaneno R; da Silva Nunes I; Fávaro WJ; de Almeida Chuffa LG
    Life Sci; 2020 Aug; 254():117786. PubMed ID: 32433918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement System Inhibition Modulates the Pro-Inflammatory Effects of a Snake Venom Metalloproteinase.
    Luchini LSG; Pidde G; Squaiella-Baptistão CC; Tambourgi DV
    Front Immunol; 2019; 10():1137. PubMed ID: 31231362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study.
    Lupi LA; Delella FK; Cucielo MS; Romagnoli GG; Kaneno R; Nunes IDS; Domeniconi RF; Martinez M; Martinez FE; Fávaro WJ; Chuffa LGA
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-mapa, a promisor immunomodulator against tumor cells of colonic tissues: An investigation of the action mechanism over the TLR4 signaling pathway.
    Socca EAR; Reis SK; Genaro SC; Leite SK; Reis IB; Bockëlmann PK; Durán N; Fávaro WJ
    Life Sci; 2020 Feb; 242():117185. PubMed ID: 31862453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of P-MAPA immunomodulator on Toll-like receptor 2, ROS, nitric oxide, MAPKp38 and IKK in PBMC and macrophages from dogs with visceral leishmaniasis.
    Melo LM; Perosso J; Almeida BF; Silva KL; Somenzari MA; de Lima VM
    Int Immunopharmacol; 2014 Feb; 18(2):373-8. PubMed ID: 24374021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.
    de Almeida Chuffa LG; de Moura Ferreira G; Lupi LA; da Silva Nunes I; Fávaro WJ
    J Ovarian Res; 2018 Jan; 11(1):8. PubMed ID: 29343281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement System Inhibition Modulates the Inflammation Induced by the Venom of
    Gabrili JJM; Villas-Boas IM; Pidde G; Squaiella-Baptistão CC; Woodruff TM; Tambourgi DV
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of P-MAPA immunomodulator on schistosomiasis.
    Silva JCS; Lins CRB; Lacerda SS; Ramos REM; Araújo HDA; Melo-Junior MR; Alves LC; Brayner FA; Nunes IS; Melo FL; Carvalho BM
    Acta Trop; 2021 Jun; 218():105909. PubMed ID: 33789153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P-MAPA Immunomodulator Partially Prevents Apoptosis Induced by Zika Virus Infection in THP-1 Cells.
    Lima MC; Azevedo EAN; de Morais CNL; de Sousa LIO; Carvalho BM; da Silva IN; Franca RFO
    Curr Pharm Biotechnol; 2021; 22(4):514-522. PubMed ID: 32484769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.
    Mollnes TE; Brekke OL; Fung M; Fure H; Christiansen D; Bergseth G; Videm V; Lappegård KT; Köhl J; Lambris JD
    Blood; 2002 Sep; 100(5):1869-77. PubMed ID: 12176911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte toll-like receptor expression in end-stage kidney disease.
    Gollapudi P; Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
    Am J Nephrol; 2010; 31(3):247-54. PubMed ID: 20090311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loxosceles venom Sphingomyelinase D activates human blood leukocytes: Role of the complement system.
    Manzoni-de-Almeida D; Squaiella-Baptistão CC; Lopes PH; van den Berg CW; Tambourgi DV
    Mol Immunol; 2018 Feb; 94():45-53. PubMed ID: 29257998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
    Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
    J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
    Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
    Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation.
    Nilsson B; Larsson R; Hong J; Elgue G; Ekdahl KN; Sahu A; Lambris JD
    Blood; 1998 Sep; 92(5):1661-7. PubMed ID: 9716594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
    O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC
    Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alginate microsphere compositions dictate different mechanisms of complement activation with consequences for cytokine release and leukocyte activation.
    Ørning P; Hoem KS; Coron AE; Skjåk-Bræk G; Mollnes TE; Brekke OL; Espevik T; Rokstad AM
    J Control Release; 2016 May; 229():58-69. PubMed ID: 26993426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
    Mirlashari MR; Lyberg T
    Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.